Alexandria Real Estate Equities Inc
NYSE:ARE

Watchlist Manager
Alexandria Real Estate Equities Inc Logo
Alexandria Real Estate Equities Inc
NYSE:ARE
Watchlist
Price: 75.73 USD -1.98% Market Closed
Market Cap: 13.1B USD

Alexandria Real Estate Equities Inc
Investor Relations

In the bustling hub of urban life sciences and technology campuses, Alexandria Real Estate Equities Inc. has carved a niche that integrates real estate acumen with a deep understanding of the life sciences industry. Born in 1994, it emerged as a visionary undertaking, keenly focused on serving the unique needs of life sciences enterprises by providing strategically located and highly sophisticated laboratory and office spaces. Headquartered in Pasadena, California, Alexandria has built a reputation not just as a landlord, but as a partner to a broad spectrum of innovative tenants ranging from biotech startups to global pharmaceutical giants. The company’s properties are primarily located in top innovation clusters like Greater Boston, San Francisco Bay Area, New York City, and San Diego, ensuring close proximity to leading research institutions and talent pools.

Alexandria’s business model thrives on a keen strategy of acquiring, developing, and operating properties in these sought-after corridors, where science and technology entrepreneurship flourishes. The company generates revenue through leasing its carefully curated real estate portfolio, with rental income forming the backbone of its financial success. Each property is designed or upgraded to meet the demanding requirements of its tenants, often including state-of-the-art laboratory facilities and amenities that foster collaboration and innovation. This not only enables Alexandria to command premium lease rates but also helps maintain high occupancy levels. The uniqueness of its properties and strategic presence in dynamic markets provide Alexandria with a strong competitive edge, underpinning its growth and establishing its stature in the specialized domain of life sciences real estate investment trusts (REITs).

Show more
Loading

Earnings Calls

2025 Q4
Apr 10, 2025
Show Transcript
Previous
Next
Constellation Brands forecasts modest beer growth amid economic challenges
2025 Q4
Apr 10, 2025

Constellation Brands reported double-digit EPS growth despite a challenging economic landscape. They project beer net sales growth of 0%-3% for fiscal '26 and 2%-4% for '27 and '28. Operating income is expected to grow by 0%-2% in '26, maintaining 39%-40% margins. Significant savings of $200 million are anticipated, with $100 million from the Wine & Spirits division due to business restructuring. The company aims for $9 billion in operating cash flow and $6 billion in free cash flow over the next three years, alongside a $4 billion share repurchase plan to enhance shareholder value.

Show Full Analysis

Management

Mr. Daniel J. Ryan
Co-President & Regional Market Director of San Diego
No Bio Available
Mr. Hunter L. Kass
Co-President & Regional Market Director of Greater Boston
No Bio Available
Mr. Marc E. Binda CPA
CFO & Treasurer
No Bio Available
Mr. Dean A. Shigenaga CPA
Strategic Consultant
No Bio Available
Mr. Lawrence J. Diamond
Co-COO & Regional Market Director of Maryland
No Bio Available
Mr. Joseph Hakman
Co-COO & Chief Strategic Transactions Officer
No Bio Available
Mr. Andres R. Gavinet CPA
Chief Accounting Officer
No Bio Available
Mr. Gregory C. Thomas
Chief Technology Officer
No Bio Available
Ms. Sara Kabakoff
Vice President of Corporate Communications
No Bio Available
Mr. John J. Cox
Senior VP & Regional Market Director of Seattle
No Bio Available

Contacts

Address
CALIFORNIA
Pasadena
26 N Euclid Ave
Contacts
+16265780777.0
www.are.com